3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
7
Pain, Postoperative
5
Leiomyoma
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Ulcer
1
Supratentorial Neoplasms
1
Sleep Wake Disorders
1
Rhabdomyosarcoma, Alveolar
1
Retinoblastoma
1
Rectal Neoplasms
1
Pulmonary Atelectasis
1
Pleural Effusion, Malignant
1
Pituitary Diseases
1
Phlebitis
1
Peripheral Nervous System Diseases
1
Patient Participation
1
Pancreatic Ductal Adenocarcinoma
1
Non-functioning Pituitary Adenoma
1
Neurotoxicity Syndromes
1
Neuralgia
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Interventions
iron isomaltoside 1000
3
ferric derisomaltose
1
Sodium Chloride
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Niferex
1
Iron
1
Endoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Anemia, Iron-Deficiency
×
Saline Solution
×
Clear all
NCT05467319
2022-07-20
FORGE
Alberta Health Services, Calgary
Phase 3
Unknown
82 enrolled